Ignite Creation Date:
2024-05-06 @ 8:40 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02796066
Status:
WITHDRAWN
Last Update Posted:
2017-04-26
First Post:
2016-05-26
Brief Title:
TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris
Sponsor:
Thesan Pharmaceuticals Inc
Organization:
Thesan Pharmaceuticals Inc
Study Overview
Official Title:
A Phase 2 Multi-Center Randomized Double-Blind Vehicle-Controlled Study to Evaluate the Safety and Efficacy of TSN2898 Topical Gel for the Treatment of Acne Vulgaris
Status:
WITHDRAWN
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Protocol not approved
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety and effectiveness of TSN 2898 topical gel in the treatment of moderate to severe acne
Detailed Description:
TSN2898 is an inhibitor of stearoyl-CoA desaturase-1 SCD-1 an enzyme present in sebaceous glands and a key regulatory enzyme in lipogenesis This study will assess the safety and efficacy of TSN2898 topical gel and matched gel vehicle applied daily on the face for the treatment of moderate to severe acne vulgaris
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None